相关实验视频

Updated: May 12, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

科尔奇辛可缓解2型糖尿病高风险患者的动脉硬:一个随机的安慰剂对照试验

Jonathan M Baier^1,2,3, Kristian L Funck^2,3, Liv Vernstrøm^1,2

¹Dept. of Clinical Medicine, Aarhus University, Aarhus, Denmark.

European journal of preventive cardiology

|March 14, 2025

概括

在2型糖尿病和心血管风险的患者中,低剂量胆固醇显著降低了动脉硬度. 这种抗炎药物可以通过改善血管健康来帮助降低心血管事件.

科学领域:

心脏病学心脏病学
内分泌学在内分泌学.
药理学药理学是指药理学的学科.

背景情况:

众所周知,抗炎药物素可以降低糖尿病和非糖尿病患者心血管疾病 (CVD) 风险.
胆固醇对心血管的益处背后的机制尚不清楚.
动脉硬和白皮尿是2型糖尿病中心血管风险的关键指标.

研究的目的:

为了研究低剂量胆固醇对2型糖尿病患者的动脉硬,门诊血压和白色素尿的影响.
为了探索菌素心脏保护作用的潜在机制.

主要方法:

一个双盲,随机,安慰剂控制的试验,涉及100名患有2型糖尿病和高心血管疾病风险的参与者.
参与者每天接受0.5毫克的胆固醇或安慰剂,持续26周.
主要结局:对于动脉硬性而言,动脉-大腿脉冲波速率 (cfPWV) 的变化. 二次结局:24小时的门诊血压 (BP) 和尿液中白蛋白与肌素的比率 (UACR).

主要成果:

胆固醇显著缓解了动脉硬性的进展 (cfPWV的MAP调整变化: -0.7 m/s,p=0.03).
原始分析显示,cfPWV (-0.3 m/s,p=0.45) 没有显著的减少.
科尔奇辛并没有显著影响24小时缩血压 (变化:3.0 mmHg,p=0.10) 或UACR (百分比变化:0.5%,p=0.98).

结论:

低剂量的胆固醇可以减少高风险2型糖尿病患者的动脉硬.
缓解动脉硬性可能有助于胆固醇所观察到的减少心血管事件.
需要进一步的研究来证实这些发现,并阐明潜在的机制.

关键词:

动脉硬性动脉硬性科尔奇辛 (Colchicine) 是一种可怕的药物.这是一种炎症炎症炎症炎症.脉冲波的速度是脉冲波的速度.2 型糖尿病 2 型糖尿病

更多相关视频

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

相关概念视频

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Peripheral Artery Disease IV: Nursing Management

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...